P, W., S, O., AH, S., & ZS, B. (2024). The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies. Biomedicines, 12(12), . https://doi.org/10.3390/biomedicines12122698
Chicago Style (17th ed.) CitationP, Wang, Okada-Rising S, Scultetus AH, and Bailey ZS. "The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies." Biomedicines 12, no. 12 (2024). https://doi.org/10.3390/biomedicines12122698.
MLA (9th ed.) CitationP, Wang, et al. "The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies." Biomedicines, vol. 12, no. 12, 2024, https://doi.org/10.3390/biomedicines12122698.
Warning: These citations may not always be 100% accurate.